🥇 投資首要原則? 懂何時省錢! 黑五前,InvestingPro 折扣高達55%。獲取優惠

浙江醫藥 (600216)

上海
貨幣 CNY
18.18
-0.38(-2.05%)
關閉

600216損益表

進階損益表
結束日期:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
總營收
aa.aaaa.aaaa.aaaa.aaaa.aa7,043.937,326.939,129.098,115.87,794.15
總營收增長
aa.aaaa.aaaa.aaaa.aaaa.aa+2.7%+4.02%+24.6%-11.1%-3.96%
營收成本
aa.aaaa.aaaa.aaaa.aaaa.aa4,271.444,409.795,529.75,437.675,392.25
毛利
aa.aaaa.aaaa.aaaa.aaaa.aa2,772.492,917.143,599.392,678.132,401.9
毛利增長
aa.aaaa.aaaa.aaaa.aaaa.aa+0.07%+5.22%+23.39%-25.59%-10.31%
毛利率%
aa.aaaa.aaaa.aaaa.aaaa.aa39.36%39.81%39.43%33%30.82%
其他營業費用—總計
aa.aaaa.aaaa.aaaa.aaaa.aa2,504.022,139.722,439.092,188.392,420.05
其他營業費用—總增長
研發費用
銷售、一般、行政費用
其他營業費用
aa.aaaa.aaaa.aaaa.aaaa.aa+9.63%-14.55%+13.99%-10.28%+10.59%
aa.aaaa.aaaa.aaaa.aaaa.aa450.42546.09806.86809.28860.07
aa.aaaa.aaaa.aaaa.aaaa.aa1,983.651,520.61,557.061,309.251,481.55
aa.aaaa.aaaa.aaaa.aaaa.aa69.9573.0475.1769.8678.43
營業收入
aa.aaaa.aaaa.aaaa.aaaa.aa268.47777.421,160.3489.74-18.15
營業收入增長
aa.aaaa.aaaa.aaaa.aaaa.aa-44.79%+189.58%+49.25%-57.79%-103.71%
EBIT利潤率%
aa.aaaa.aaaa.aaaa.aaaa.aa3.81%10.61%12.71%6.03%-0.23%
淨利息費用
aa.aaaa.aaaa.aaaa.aaaa.aa19.3493.2917.89-19.94-11.82
淨利息費用增長
aa.aaaa.aaaa.aaaa.aaaa.aa+317.01%+382.37%-80.83%-211.45%+40.69%
利息費用—總計
aa.aaaa.aaaa.aaaa.aaaa.aa-25.71-46.27-39.54-33.11-28.34
利息和投資收入
aa.aaaa.aaaa.aaaa.aaaa.aa45.05139.5657.4213.1816.51
其他非營業開支—總計
aa.aaaa.aaaa.aaaa.aaaa.aa10.54-70.33-6729.8757.68
EBT(不含不尋常項目)
aa.aaaa.aaaa.aaaa.aaaa.aa298.35800.381,111.18499.6727.7
出售資產損益
aa.aaaa.aaaa.aaaa.aaaa.aa-2.07-23.48-7.95-1.37323.57
其他不尋常項目—總計
aa.aaaa.aaaa.aaaa.aaaa.aa39.3743.6-1.4357.7149.82
EBT(含不尋常項目)
aa.aaaa.aaaa.aaaa.aaaa.aa397.5850.981,153.53491.39363.28
EBT(含不尋常項目)增長
aa.aaaa.aaaa.aaaa.aaaa.aa-10.35%+114.09%+35.55%-57.4%-26.07%
EBT(含不尋常項目)利潤率
aa.aaaa.aaaa.aaaa.aaaa.aa5.64%11.61%12.64%6.05%4.66%
所得稅費用
aa.aaaa.aaaa.aaaa.aaaa.aa105.54191.34268.97128.7786.48
企業淨收入
aa.aaaa.aaaa.aaaa.aaaa.aa291.95659.64884.56362.61276.79
少數股權
aa.aaaa.aaaa.aaaa.aaaa.aa50.8257.76160.76176.96152.85
淨收入
aa.aaaa.aaaa.aaaa.aaaa.aa342.77717.41,045.32539.57429.64
淨收入增長
aa.aaaa.aaaa.aaaa.aaaa.aa-5.97%+109.29%+45.71%-48.38%-20.37%
淨收入率%
aa.aaaa.aaaa.aaaa.aaaa.aa4.87%9.79%11.45%6.65%5.51%
優先股及其他調整
aa.aaaa.aaaa.aaaa.aaaa.aa-----
普通股淨收入(不含特別項目)
aa.aaaa.aaaa.aaaa.aaaa.aa342.77717.41,045.32539.57429.64
基本每股收益—持續營運
aa.aaaa.aaaa.aaaa.aaaa.aa0.360.751.090.560.45
基本每股收益—持續營運增長
aa.aaaa.aaaa.aaaa.aaaa.aa-5.26%+108.33%+45.33%-48.62%-20.13%
稀釋後每股收益—持續營運
aa.aaaa.aaaa.aaaa.aaaa.aa0.360.751.090.560.45
稀釋後每股收益—持續營運增長
aa.aaaa.aaaa.aaaa.aaaa.aa-5.26%+108.33%+45.33%-48.62%-20.13%
基本加權平均流通在外股數
aa.aaaa.aaaa.aaaa.aaaa.aa952.15956.53959.01963.52960.53
稀釋後加權平均流通在外股數
aa.aaaa.aaaa.aaaa.aa